DOI QR코드

DOI QR Code

Development of a High-performance COVID-19 Diagnostic Kit Employing Improved Antibody-quantum dot Conjugate

  • Seongsoo Kim (Department of Biomedical Laboratory Science, Eulji University) ;
  • Hyunsoo Na (Department of Industrial Electronics Research Institute, BK Electronics) ;
  • Hong-Geun Ahn (Department of Industrial Electronics Research Institute, BK Electronics) ;
  • Han-Sam Park (Department of Industrial Electronics Research Institute, BK Electronics) ;
  • Jaewoong Seol (Department of Biomedical Laboratory Science, Eulji University) ;
  • Il-Hoon Cho (Department of Biomedical Laboratory Science, Eulji University)
  • Received : 2023.11.22
  • Accepted : 2023.12.08
  • Published : 2023.12.31

Abstract

This study emphasizes the importance of early diagnosis and response to COVID-19, leading to the development of a rapid diagnostic kit using quantum dots. The research focuses on finely tuning bioconjugation with quantum dots to enhance the accuracy and sensitivity of COVID-19 diagnosis. We have developed a COVID-19 rapid diagnostic kit that exhibits a sensitivity more than 50 times higher than existing COVID-19 diagnostic kits. Quantum dots enable the accurate detection of COVID-19 viral antigens even at low concentrations, providing a rapid response in the early stages of infection. The COVID-19 quantum dot diagnostic kit offers quick analysis time, utilizing the quantum properties of particles to swiftly measure COVID-19 infection for immediate response and isolation measures. Additionally, this diagnostic kit allows for multiple analyses with ease, as multiple quantum dots can detect various antigens and antibodies simultaneously in a single experiment. This efficiency enhances testing, reduces sample requirements, and lowers experimental costs. The application of this diagnostic technology is anticipated in the future for early diagnosis and monitoring of other infectious diseases.

Keywords

Acknowledgement

This work was supported by Korea institute for Advancement of Technology (KIAT) grant funded by the Korea Government (MOTIE) (P0018665).

References

  1. Gao S, Guisan JM, Rocha-Martin J. Oriented immobilization of antibodies onto sensing platforms - A critical review. Anal Chim Acta. 2022. 1189: 338907.
  2. Jendroszek A, Kjaergaard M. Nanoscale spatial deprndence of avidity in an IgG1 antibody. Sci Rep. 2021. 11: 11263.
  3. Heo JY. Clinical and Epidemiological Characteristics of Coronavirus Disease 2019 in the Early Stage of Outbreak. KJM. 2020. 95: 67-73. https://doi.org/10.3904/kjm.2020.95.2.67
  4. Kim JW, Heu WS, Jeong SY, et al. Genetically functionalized ferritin nanoparticles with a high-affinity protein binder for immunoassay and imaging. Analytica Chimica Acta. 2017. 988: 81-88. https://doi.org/10.1016/j.aca.2017.07.060
  5. Kim MN, Kim HS, Bae HG, et al. Laboratory Diagnosis and Utilization for COVID-19. KJICP. 2021. 26: 47-56. https://doi.org/10.14192/kjicp.2021.26.2.47
  6. Mei BC, Susumu K, Medintz IL, et al. Polyethylene glycol-based bidentate ligands to enhance quantum dot and gold nanoparticle stability in biological media. Nat Protoc. 2009. 4: 412-423. https://doi.org/10.1038/nprot.2008.243
  7. Mousavi SM, Hashemi SA, Kalashgrani MY, et al. The Pivotal Role of Quantum Dots-Based Biomarkers Integrated with Ultra-Sensitive Probes for Multiplex Detection of Human Viral Infections. Pharmaceuticals. 2022. 15: 8.
  8. Parolo C, Escosura-Muntz A de la, Grazy V, et al. Design, Preparation, and Evaluation of a Fixed-Orientation Antibody/Gold-Nanoparticle Conjugate as an Immunosensing. ACS Appl. 2015. 5: 10753-10759. https://doi.org/10.1021/am4029153
  9. Zhu ZJ, Yeh YC, Tang R, et al. Stability of quantum dot in live cells. Nat Chem. 2011. 3: 963-968. https://doi.org/10.1038/nchem.1177